Misako Nagasaka

Associate Professor at School of Medicine, University of California-Irvine0 Followers

Professor with a reputation for excellence in the field of Hematology and Oncology, Misako Nagasaka serves as an Associate Professor at the UCI School of Medicine. Her academic journey and professional endeavors have significantly contributed to the advancement of medical education and research at the University of California-Irvine. Professor Nagasaka's role at the Division of Hematology/Oncology involves both teaching and engaging in cutting-edge research, although her specific research interests remain unspecified. Her commitment to the medical community is evident in her active participation in various academic and clinical initiatives. For those wishing to reach out to her, she is available at 1001 Health Sciences Road, Irvine, CA 92697.

Research Interests

Hematology Oncology Medical education Clinical research

Publications

1 - Abstract 1058: Inhibition of nuclear transport protein XPO1 potentiates the effect of KRASG12C inhibitors,Cancer Research

Husain Y. Khan , Md. Hafiz Uddin , Yue Zhang , Yosef Landesman , Ammar Sukari , Misako Nagasaka , Asfar S. Azmi ,

, 1058-1058, 2021-07-01

2 - A comprehensive survey of tumor mutation burden (TMB) using the AACR GENIE cbioportal database: Pathogenesis of NTRK and RET fusion (NTRK+/RET+) positive colorectal (CRC).,JCO Global Oncology

Zhaohui Arter , Alexandria TM Lee , Misako Nagasaka , Sai-Hong Ignatius Ou ,

, 33-33, 2023-08-01

3 - NTRK fusion positive colorectal cancer as a unique subset of CRC with high tumor mutation burden and microsatellite instability.,Journal of Clinical Oncology

Hui WANG , Qiuxiang Ou , Xue Wu , Misako Nagasaka , Sai-Hong Ignatius Ou , Yang Shao ,

, 3544-3544, 2021-05-20

4 - Surgical outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis.,Journal of Clinical Oncology

Riona Aburaki , Yu Fujiwara , Kohei Chida , Nobuyuki Horita , Misako Nagasaka ,

, 8020-8020, 2024-06-01

5 - Predictors of early readmission to hospital and mortality in patients with malignant ascites: Analysis of the nationwide readmissions database.,Journal of Clinical Oncology

Omid Yazdanpanah , Tanveer Mir , Sohaip Kabashneh , Ibrahim Azar , Misako Nagasaka , Mohammed Najeeb Al Hallak ,

, 12057-12057, 2021-05-20

6 - Survey of actionable driver mutations KRAS and EGFR in non–small cell lung cancer to evaluate coexisting splicing gene and pathway mutations: A CBioportal database analysis.,Journal of Clinical Oncology

Zhaohui Arter , Misako Nagasaka , Sai-Hong Ignatius Ou ,

, 8561-8561, 2024-06-01

7 - Toxicities associated with checkpoint inhibitor immunotherapy: The Karmanos Cancer Center experience.,Journal of Clinical Oncology

Misako Nagasaka , Roba S Alhasan , Marcus Crosby , Nithin Thummala , Seongho Kim , Judith Abrams , Ammar Sukari ,

, e14575-e14575, 2017-05-20

8 - Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck,The Laryngoscope

Misako Nagasaka , Mark Zaki , Majd Issa , Harold Kim , Judith Abrams , Ammar Sukari ,

, 2260-2264, 2017-03-08

9 - Radiation therapy and immune-related side effects in patients treated with PD-1 inhibitors.,Journal of Clinical Oncology

Nadine Abdallah , Suketu Nagin Patel , Misako Nagasaka , Seongho Kim , Harold E. Kim , Ammar Sukari ,

, 207-207, 2018-02-10

10 - The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer—A Narrative Review,Cancers

Robert Hsu , David J. Benjamin , Misako Nagasaka ,

, 3561, 2023-07-10

11 - The development of amivantamab for the treatment of non-small cell lung cancer,Respiratory Research

Danielle Brazel , Misako Nagasaka ,

, 2023-10-25

12 - Gastrostomy tube dependence and patient‐reported quality of life outcomes based on type of treatment for human papillomavirus‐associated oropharyngeal cancer: Systematic review and meta‐analysis,Head & Neck

Daniel L. Quan , Ammar Sukari , Misako Nagasaka , Harold Kim , John D. Cramer ,

, 3681-3696, 2021-07-29

13 - Liquid Biopsy to Identify Actionable Genomic Alterations,American Society of Clinical Oncology Educational Book

Sai-Hong Ignatius Ou , Misako Nagasaka , Viola W. Zhu ,

, 978-997, 2018-05-01

14 - Is this really just “fatigue”? A case series of immune‐related central adrenal insufficiency secondary to immune checkpoint inhibitors,Clinical Case Reports

Misako Nagasaka , Nadine Abdallah , Julie Samantray , Ammar Sukari ,

, 1278-1281, 2018-05-24

15 - Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC,Targeted Oncology

Danielle Brazel , Misako Nagasaka ,

, 297-301, 2024-05-01

16 - Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC,Lung Cancer: Targets and Therapy

Danielle Brazel , Misako Nagasaka ,

, 47-52, 2022-05-01

Share Misako's Profile